Results 11 to 20 of about 165,068 (304)

Access to medicines: relations with the institutionalization of pharmaceutical services [PDF]

open access: yesRevista de Saúde Pública, 2017
OBJETIVE To analyze the relationship between access to medicines by the population and the institutionalization of pharmaceutical services in Brazilian primary health care. METHODS This study is part of the Pesquisa Nacional sobre Acesso, Utilização e
Rafael Damasceno de Barros   +11 more
doaj   +4 more sources

PHARMACEUTICAL SERVICES: STATUS AND DEVELOPMENT TRENDS

open access: yesФармация и фармакология (Пятигорск), 2021
The aim of the review is to provide an analysis and generalization of the main directions of research in the sphere of pharmaceutical services, and their characteristics associated with the determination of their main development trends.Materials and ...
A. A. Klimenkova   +4 more
doaj   +3 more sources

Different models of pharmaceutical services and care in primary healthcare clinics in the Eastern Cape, South Africa: Challenges and opportunities for pharmacy practice [PDF]

open access: yesAfrican Journal of Primary Health Care & Family Medicine, 2020
Background: Primary health care (PHC) re-engineering forms a crucial part of South Africa’s National Health Insurance (NHI), with pharmaceutical services and care being crucial to treatment outcomes. However, owing to a shortage of pharmacists within PHC
Amy C. Bobbins   +2 more
doaj   +2 more sources

Community Pharmaceutical Services Implemented in Shanghai [PDF]

open access: yesZhongguo quanke yixue, 2022
Background Most of the elderly are prone to more than two chronic diseases and polypharmacy. Community health institutions are the key to ensuring rational drug use for in this population.
Manhua QIAO, Wenhui WU, Zhenwei LIU, Muhan CHEN, Cao WANG, Qi TANG, Jun LYU, Gang CHEN
doaj   +2 more sources

MARKETING STUDIES OF ADDITIONAL SERVICES RENDERED IN PHARMACEUTICAL ORGANIZATIONS OF THE REPUBLIC OF NORTH OSSETIA – ALANIA

open access: yesФармация и фармакология (Пятигорск), 2015
Market changes in Russian economy have significantly influenced the pharmaceutical market and changed the working conditions of pharmaceutical organizations.
L. N. Tsarakhova, I. L. Levkova
doaj   +3 more sources

Conceptions on pharmaceutical services in Brazilian primary health care [PDF]

open access: yesRevista de Saúde Pública, 2017
OBJECTIVE To identify and discuss the conceptions of pharmaceutical services in Brazilian Primary Health Care, according to different subjects. METHODS This study is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de ...
Ediná Alves Costa   +11 more
doaj   +2 more sources

Quality of Pharmaceutical Services in Independent Pharmacies and Pharmacy Chains in Poland from the Patient Perspective [PDF]

open access: yesPatient Preference and Adherence, 2020
Karolina Bratkowska,1 Urszula Religioni,2 Jerzy Krysiński,1 Piotr Merks1,3 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland; 2Collegium of Business Administration, Warsaw School of Economics,
Bratkowska K   +3 more
doaj   +2 more sources

Key performance indicators for pharmaceutical services: A systematic review [PDF]

open access: yesExploratory Research in Clinical and Social Pharmacy
Inajara Rotta   +2 more
exaly   +2 more sources

Examination of the need for additional pharmaceutical services and selected elements of pharmaceutical care in Poland – pilot study [PDF]

open access: yesFarmacja Polska, 2021
Background: A pharmacy is a healthcare facility where authorised personnel provides, pharmaceutical services. In accordance with the implementation of the Act on the Pharmacy Profession from April 16, 2021 in Poland, pharmaceutical care is defined as a ...
Natalia Wrzosek   +6 more
doaj   +1 more source

Population PK modelling as an alternative route to bioequivalence

open access: yesBritish Journal of Pharmacy, 2022
Demonstrating bioequivalence (BE) is important for the development of lower-cost generic products, and also for approving post-submission manufacturing changes. However, for many complex parenteral products, BE demonstration can be very challenging.
Parmesh Gajjar   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy